http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008020286-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5481b52b8ad9ae6493ffc18285793dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b29a3203c871d75a3ecec935f3abf0a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8af4dc792d2b921a627172ec391532eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cec5ae1ac9d7a26b60d4ee2ff5b1189d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ec06dd5cbefa50a72d20ae8f552548b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2007-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60025b5f8adc5afe8baa72f6a29349d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f99c0987032d476a29810afdb270f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9174e155b4d7bc5c51f6eaa3e5e9bcec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd43c0f841b5a1e22b8a2408a5f424e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5472956194f934014a72c44b5ed50491
publicationDate 2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008020286-A3
titleOfInvention Pharmaceutical compositions of duloxetine
abstract The present invention relates to solid oral pharmaceutical compositions of duloxetine, process for preparing such compositions and method of using such compositions. Preferably, the invention relates to a delayed release composition of duloxetine comprising a core comprising duloxetine, optional separating coat and an enteric coat, wherein the enteric coat comprises methacrylic acid copolymer.
priorityDate 2006-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5508276-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1640000-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006165776-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007139886-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5910319-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60835

Total number of triples: 37.